The effect of augmentation therapy on bronchial inflammation in α1-antitrypsin deficiency

American Journal of Respiratory and Critical Care Medicine

Volumn 165, Issue 11, 2002, Pages 1494-1498

  Stockley, Robert A ^a   Bayley, Darren L ^a   Unsal, Ipek ^a   Dowson, Lee J ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

1 antitrypsin; Inflammation; Leukotriene B4; Sputum

Indexed keywords

ALPHA 1 ANTITRYPSIN; CHEMOATTRACTANT; CYTOKINE; ELASTASE; INTERLEUKIN 8; LEUKOTRIENE B4; MYELOPEROXIDASE;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; BRONCHITIS; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE PREDISPOSITION; DOSE TIME EFFECT RELATION; EMPHYSEMA; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HUMAN; IMMUNOREGULATION; NEUTROPHIL; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SECRETION;

ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; BIOLOGICAL MARKERS; BRONCHITIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; INTERLEUKIN-8; LEUKOTRIENE B4; MALE; PANCREATIC ELASTASE; PEROXIDASE; PROGNOSIS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SPUTUM; TREATMENT OUTCOME;

EID: 0036606880     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.2109013     Document Type: Article

References (27)

1. Clinical features and history of the destructive lung disease associated with α1-antitrypsin deficiency of adults with pulmonary symptoms
2. Pathological findings in alpha-1 antitrypsin deficiency
3. Alpha-1-antitrypsin deficiency: What next?
4. Airways inflammation in chronic bronchitis: The effects of smoking and α1-antitrypsin deficiency
5. Antineutrophil elastase defences of the lower respiratory tract in α1-antitrypsin deficiency, direct augmentation with aerosol α1-antitrypsin
6. Quantum proteolysis by neutrophils: Implications for pulmonary emphysema and alpha-1-antitrypsin deficiency
7. Neutrophil accumulation in the lung in alpha-1-antitrypsin deficiency: Spontaneous release of leukotriene B4 from alveolar macrophages
8. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with α1-antitrypsin deficiency (Pi Z)
9. Longitudinal changes in physiological, radiological, and health status measurements in α1-antitrypsin deficiency and factors associated with decline
10. Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: A new hypothesis with supporting data
11. Replacement therapy for alpha-1-antitrypsin deficiency associated with emphysema
12. Replacement therapy of alpha-1-antitrypsin deficiency: Reversal of protease-anti-protease balance within alveolar structures of Pi Z subjects
13. Low molecular mass bronchial proteinase inhibitor and α1-proteinase inhibitor in sputum and bronchoalveolar lavage
14. Biochemical efficacy and safety of monthly augmentation therapy for α1-antitrypsin deficiency
15. Anti-elastases of human alveolar structures: Implications for the protease-antiprotease theory of emphysema
16. The assessment of α1-proteinase inhibitor form and function in lung lavage fluid from healthy subiects
17. The functional activity of α1-proteinase inhibitor in bronchoalveolar lavage fluids from healthy human smokers and non-smokers
18. Lung lavage fluid from patients with al-proteinase inhibitor deficiency or chronic obstructive bronchitis: Anti-elastase function and cell profile
19. Activation of human leukocyte elastase by α2 macroglobulin
20. Elastase inhibitors in sputum from bronchitic patients with and without α1-proteinase inhibitor deficiency: Partial characterization of a hitherto unquantified inhibitor of neutrophil elastase
21. 1-proteinase inhibitor and bronchial anti leukoprotease: Different results using insoluble elastin or synthetic low molecular weight substrates
22. Alpha-1-antitrypsin and leukocyte elastase in infected and non-infected sputum
23. The effect of catalase and methionine-S-oxide reductase on oxidised α1-proteinase inhibitor
24. Short-term supplementation therapy does not affect elastin degradation in severe AAT deficiency: The American-Italian AATD Study Group
25. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line
26. Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid
27. Sputum chemotactic activity in chronic obstructive pulmonary disease: The effect of alpha-1-antitrypsin deficiency